SOLICITATION NOTICE
R -- Development of Health Communication Materials and Plan for Reducing Pediatric Radiation Dose from Medical Imaging - Solicitation Information
- Notice Date
- 6/12/2009
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- 09-223-SOL-00101
- Archive Date
- 7/29/2009
- Point of Contact
- London L Johnson, Phone: 301-827-7041, Christopher E. Cunningham, Phone: 301-827-7185
- E-Mail Address
-
london.johnson@fda.hhs.gov, christopher.cunningham@fda.hhs.gov
(london.johnson@fda.hhs.gov, christopher.cunningham@fda.hhs.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- Evaluation Criteria in-depth Security Information The U.S. Food and Drug Administration (FDA) are seeking small businesses [HUBZone, Service-Disabled Veteran-owned, small disadvantaged, 8(a), and woman-owned, minority-owned] ONLY, that can develop health communication materials for reducing ionizing radiation exposure to pediatric population from medical imaging. This a combined synopsis/solicitation for commercial items (as defined by FAR 2.101) prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation. A written request for proposals will not be issued. This acquisition is subject to FAR Subpart 13.5 regarding the application of simplified acquisition procedures. This acquisition is issued as Request for Proposal 09-223-SOL-00101. All responsible small business sources may submit an offer that will be considered. The North American Industry Classification System (NAICS) code is 541990. The small business size standard is $7 million. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 05-32. Offers in response to this RFP shall be submitted by 12:00 pm Eastern Daylight Time, July 14, 2009. I. Background-Radiation Exposure from Medical Imaging-The National Council on Radiation Protection NCRP press release of March 2009 states that in 2006, Americans were exposed to more than six times as much ionizing radiation from medical procedures as was the case in the early 1980s. In 2006, medical exposure constituted nearly half of the total radiation exposure of the U.S. population from all sources. The increase was primarily a result of the growth in the use of medical imaging procedures. The increase was due mostly to the higher utilization of computed tomography (CT) and nuclear medicine. These two imaging modalities alone contributed 36 percent of the total radiation exposure and 75 percent of the medical radiation exposure of the U.S. population. The number of CT scans and nuclear medicine procedures performed in the United States during 2006 was estimated to be 67 million and 18 million, respectively. www.ncrponline.org. Pediatric population-Children are more sensitive to radiation received from medical imaging scans than adults. One factor to consider is that children have more rapidly dividing cells that can be exposed to the low-level radiation. Also, they have a longer expected lifetime for the effects of radiation exposure to manifest as cancer. That is why it is important that with children, the lowest radiation dose necessary is used for providing an image from which an accurate diagnosis can be made. FDA's Center for Devices and Radiological Health (CDRH) regulates medical imaging devices. Among its many responsibilities is helping consumers keep informed about minimizing unnecessary radiation exposure in medical procedures. A health communication plan for addressing radiation from medical imaging for pediatric population can play a vital role in reducing public health risks from radiation. http://www.fda.gov/consumer/updates/radiology_kids062308.html. II. Scope of Work- FDA/CDRH is requesting development of health communication materials for reducing ionizing radiation exposure to pediatric population from medical imaging. CDRH’s investment will increase awareness of the public health importance of reducing radiation exposure for pediatric population. Specific target audience(s) and justification for target audiences (may include consumers, health care providers, etc) for these materials will be developed by the contractor. The contractor will deliver to CDRH a health communication plan which will include recommendations for: 1) Key messages, 2) Channels of communication 3) Characteristics of the target audience(s), 4) Potential barriers to communication. The contractor will also develop health communication materials that incorporate information from the recommendations above. III. Period of Performance- Date of Award through six months. The Contractor shall begin no later than 7 days after award. IV. Deliverables- In developing a health communication plan and health communication materials, the contractor will complete the following tasks with the overall goal of creating health communication materials to reduce radiation exposure from medical imaging for pediatric populations: 1) Conduct initial meeting with FDA project officer and technical experts to discuss goals and develop common understanding of objectives for the project, 2) Draft of the health communication plan, including a timeline with justification for all deliverables, 3) Monthly status reports.The status report will include a summary of actions taken since the previous status report and will note any delays which might affect the final completion date of the project, 4) Written health communication plan, 5) Drafts of health communication materials to review and approve before final production, 6) 100 copies of the final health communication material due prior to completion of the contract, 7) Electronic copy of health communication material in original editable format and in webpage format. V. Section 508 Requirements- All electronic and information technology (EIT) procured through this award must meet the applicable accessibility standards at 36 CFR 1194, unless an agency exception to this requirement exists. 36 CFR 1194 implements Section 508 of the Rehabilitation Act of 1973, as amended, and is viewable at http://www.access-board.gov/508.htm. The contractor shall indicate whether each product is compliant or non-compliant with the accessibility stands at 36 CFR 1194. VI. Release of Information and Confidentiality-The Contractor shall not disseminate any information concerning the specific project without prior approval of CDRH. All rights and ownership for the training developed under this agreement shall reside with FDA. The Contractor shall guarantee strict confidentiality of the information/ data that it is provided by the Government during the performance of the task order. Disclosure of the information/ data, in whole or in part, by the contractor can only be made after the Contractor receives prior written approval from the Contracting officer (s). Whenever the Contractor is uncertain with regard to the proper handling of information/ data under this agreement, the Contractor shall obtain a written determination from the Contracting Officer. [Attachment 1 of this announcement is the Security Information]. VIII. Contract Administration-Designation of Contracting Officer: Mrs. London Johnson, Contracting Officer, Division of Acquisitions, Operations, Service Contract Team, will administer the contractual aspects of this award. Changes in the scope, purchase order cost, price, quantity, quality or delivery schedule shall be made only by the Contracting Officer with a properly executed modification. All correspondence which concerns the terms and conditions of this purchase order shall be submitted directly to the Contracting Officer via email at London.Johnson@fda.hhs.gov. The Contracting Officer Technical Representative (COTR) shall be announced at the time of award. However, the COTR cannot make any changes that affect the contract amount, terms or conditions. The Contracting Officer is the only authorized agent of the Government under this contract. Only the Contracting Officer has the authority to 1) direct or negotiate any changes in the Statement of Work, 2) modify or extend the period of performance, 3) change the delivery schedule, 4) otherwise change any terms and conditions of this award. IX. Terms and Conditions- The provisions of FAR PART 52.212-4 Contract Terms and Conditions-Commercial Items (MAR 2009) and FAR PART 52.212-5- Contract Terms and Conditions Required to Implement Statutes or Executive Orders—Commercial Items (MAY 2009) are incorporated by Reference. FAR PART 52.212-5 applies as follows: A2, A3, B8i, B15, B16, B18, B19, B21, B22, B24, B34, and B39. 2) 52.212-8-Option to Extend Services (NOV 1999)[Fill-in: 30 days]. X. Instructions for Submitting Proposals: The provisions at FAR PART 52.212-1 Instructions to Offerors-Commercial items (JUN 2008) are incorporated by reference. Offerors shall follow these instructions. Experience shall be limited to current projects and/or projects completed within the past 3 years; (c) Period of Acceptance for offers is 90 calendar days; (d)(e)(h), and (i) do not apply. Completed Representations and Certifications as required by FAR 52.212-3 Offeror Representations and Certifications-Commercial Items (FEB 2009) shall be submitted with this offer. Offerors who fail to include all required information may be rejected without further consideration. XI. Evaluation Criteria- The provision at 52.212-2 is incorporated by reference with the following fill-in information. A) Award will be made on a Best Value basis taking into account the following factors: 1) Relevant Experience, 2) Past Performance, 3) Personnel Resources, and 4) Cost/Price. B) Relative Experience, Past Performance, and Personal Resources, when combined, are equally important as cost or price. The Government may make an award to other than the lowest priced offer based on a trade-off among these factors. [Attachment 2 describes the evaluation criteria in-depth].
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/09-223-SOL-00101/listing.html)
- Record
- SN01843712-W 20090614/090612235732-2be82b69ce259a73dcd911485b0ab962 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |